Patents by Inventor Paul Tamburini

Paul Tamburini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING A COMPLEMENT MEDIATED DISORDER CAUSED BY AN INFECTIOUS AGENT IN A PATIENT
    Publication number: 20160168237
    Abstract: The present disclosure relates to, inter alia, a method of treating a complement mediated disorder caused by an infectious agents in a patient, comprising administering an effective amount of a C5 inhibitor, such as eculizumab or an eculizumab variant, to the patient.
    Type: Application
    Filed: December 11, 2015
    Publication date: June 16, 2016
    Inventors: Darrell Fontenot, Bridget Puffer, Bruce Andrien, Mittie Doyle, Paul Tamburini, Camille Bedrosian
  • ANTI-MN ANTIBODIES AND METHODS OF USING SAME
    Publication number: 20120301468
    Abstract: The invention provides antibodies having an antigenic binding site specifically directed against an MN protein, and methods of using such antibodies in treating and diagnosing an MN-related disorder.
    Type: Application
    Filed: April 30, 2012
    Publication date: November 29, 2012
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Paul Tamburini, Gerald Ranges, Lila Adnane, Timothy McCabe, Pamela Trail, Sha Ha
  • Anti-MN antibodies and methods of using same
    Patent number: 8168758
    Abstract: The invention provides antibodies having an antigenic binding site specifically directed against an MN protein, and methods for using such antibodies in treating and diagnosing an MN-related disorder.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: May 1, 2012
    Assignee: Bayer HealthCare LLC
    Inventors: Paul Tamburini, Gerald Ranges, Lila Adnane, Timothy Mccabe, Pamela Trail, Sha Ha
  • Anti-MN Antibodies and Methods of Using Same
    Publication number: 20100129315
    Abstract: The invention provides antibodies having an antigenic binding site specifically directed against an MN protein, and methods for using such antibodies in treating and diagnosing an MN-related disorder.
    Type: Application
    Filed: December 12, 2006
    Publication date: May 27, 2010
    Applicant: Bayer Healthcare LLC
    Inventors: Paul Tamburini, Gerald Ranges Hamden, Lila Adnane, Timothy McCabe, Pamela Trail, Sha Ha
  • Human bikunin
    Publication number: 20060172946
    Abstract: The instant invention provides for proteins, polypeptides, nucleic acid sequences, constructs, expression vectors, host cells, pharmaceutical compositions of, and methods for using human placental bikunin, serine protease inhibitor domains, and fragments thereof.
    Type: Application
    Filed: March 27, 2006
    Publication date: August 3, 2006
    Inventors: Paul Tamburini, Gary Davis, Katherine Delaria, Christopher Marlor, Daniel Muller